CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Gennex Laboratories Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Gennex Laboratories Ltd
Akash Ganga 3rd Floor
Plot No 144, Srinagar Colony
Phone: +91 4067334400p:+91 4067334400 HYDERABAD, 500073  India Ticker: 531739531739
Business Summary
Gennex Laboratories Limited is an India-based active pharmaceutical ingredient manufacturing company. The Company is engaged in the business of manufacturing bulk drugs, intermediaries, and biotech products. The Company has a robust product portfolio spread over product segments encompassing Expectorants, Muscle Relaxants, Analgesic and Anti-Fungal. The Company operates through the Pharmaceutical Products (Bulk Drugs) segment. The Company's products include active pharmaceutical ingredients, such as Guaifenesin USP/BP/EP/IP, which is an expectorant, (mucolyte); Methocarbamol USP/IP, which is a relaxant (skeletal muscle relaxant); Phenazopyridine Hcl USP, which is an urinary tract analgesic; Fluconazole EP/BP/USP/IP, which is an anti-fungal product; Mephenesin IP/BP, which is a muscle relaxant; Sertraline Hcl, which is a selective serotonin reuptake inhibitors (SSRIS), and others. The Company has manufacturing facilities in India which cater to both domestic and international markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20243/31/2024Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Operating Officer, Compliance Officer K. V.Bhaswanth
Managing Director, Director ArihantBaid 5/18/2012 5/18/2012
Whole Time Director Tiruvarur M.Gopalakrishnan 5/18/2012 5/18/2012
Non-Executive Independent Director U. C.Bhandari 60 3/22/2003 3/22/2003
Non-Executive Independent Director Yellu R.Reddy 55

Business Names
Business Name
531739
890171
Gennex Laboratories Ltd

General Information
Outstanding Shares: 227,447,674 (As of 3/31/2024)
Shareholders: 5,731
Stock Exchange: BOM
Fax Number: +91 4067334401


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024